Effect of Soleus Muscle Kinetic Control Training on Gait and Electromyographic Activity in Patients With Stroke
Overview
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Cairo University
- Enrollment
- 40
- Primary Endpoint
- muscle amplitude
Overview
Brief Summary
this study was designed to investigate the effect of soleus muscle kinetic control training on Gait and electromyographic activity of the calf muscle in patients with stroke
Detailed Description
Stroke is a neurological condition characterized by a reduced blood supply to the brain tissue, resulting in paralysis of part or all of the body, limiting physical activity and social participation. Gait impairment accounts for the largest proportion of physical activity limitations in stroke patients and is characterized by muscle weakness, foot drop, spasticity, and foot deformity .Gait abnormalities following stroke are often disabling. Reduced ankle dorsiflexion, knee flexion, or hip flexion torques are often postulated causes of compromised toe clearing during the swing phase of gait. conversely, gait asymmetry and reduced walking speed has been attributed to weakness of the planter flexors.The kinetic control comprises balanced presentation of the movement choices with ideal interaction among the key components for the sensorimotor neuromuscular control that mediated by afferent sensory input, particularly the proprioceptive input, CNS integration, optimal motor co-ordination, and physiological stresses to assure functional dynamic stability and controlled mobility. forty patients with stroke will be assigned to two groups; one group will recieve kinetic control plus conventional therapy and control group will receive conventinoal therapy alone.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Single (Outcomes Assessor)
Masking Description
opaque sealed envelope
Eligibility Criteria
- Ages
- 45 Years to 60 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Ischemic or hemorrhagic stroke, as confirmed by CT and or MRI scan.
- •Age of the patients between 45 to 60 years old.
- •Ability to walk a minimum of 10 m with or without some physical assistance from a therapist (functional ambulation category more than 2).
- •Demonstrate weakness of the foot muscles, measured by muscle function tests according Medical Research council scale more than
- •Muscle tone of the affected lower limb ranges from 1 to +1 according to modified Ashworth scale.
Exclusion Criteria
- •Unilateral neglect, hemianopia, or apraxia
- •Having any other neurological disorder affecting their lower extremities e.g. MS, Parkinsonism, peripheral neuropathy.
- •Patients with previous fractures in lower limb (Ankle or foot).
- •Patients with musculoskeletal disorder such as severe arthritis, ankle surgery, leg length discrepancy or contractures of fixed deformity of ankle joint.
- •Patients with visual, auditory impairment affecting their ability to complete tasks.
- •Patients with cognitive impairments
Outcomes
Primary Outcomes
muscle amplitude
Time Frame: up to eight weeks
A steady device will be used to assess muscle amplitude in the form of RMS with microvolt as the measurement unit
stance phase percentage
Time Frame: up to eight weeks
the percentage of stance phase will be measured by steady device
giat function
Time Frame: up to eight weeks
The Dynamic Gait Index (DGI) is an ordinal test of gait function evaluates the capacity to adapt gait to complex walking tasks encountered in everyday life. Eight aspects of gait are scored based on observation as the patient walks over a 6.1-m level surface. The rater records an ordinal score that ranges from 0 (unable or done very poorly) to 3 (normal score) for a total point value of 24. Scores of less than 21 appear to suggest risk for falls
step time
Time Frame: up to eight weeks
the time of step by seconds will be measured by steady device
Gait Cycle time
Time Frame: up to eight weeks
time of gait cycle (seconds) will be measured by steady device
single and double support percentage
Time Frame: up to eight weeks
single and double support percentage of gait cycle will be measured by steady device
stride length
Time Frame: up to eight weeks
stride length by cm will be measured by steady device
swing phase percentage
Time Frame: up to eight weeks
the percentage of swing phase will be measured by steady device
cadence
Time Frame: up to eight weeks
Cadence, number of steps per minute, will be measured by steady device
first and second double support percentage
Time Frame: up to eight weeks
first and second double support percentage of gait cycle will be measured by steady devcie
gait speed
Time Frame: up to eight weeks
gait speed by km/h will measured by steady device
Secondary Outcomes
No secondary outcomes reported
Investigators
Habiba Mohamed Ahmed Mahmoud
principle investigator : habiba mohamed ahmed mahmoud
Cairo University